Study Objective: This study aims to see how well people can give themselves a medicine called rocatinlimab at home. This medicine is for moderate-to-severe atopic dermatitis (AD), a skin condition that causes itchy and red skin. Participants will use special devices to inject the medicine under their skin.
Eligibility: To join, you must be at least 12 years old and have had AD for over a year. You should have tried certain creams (like medium to strong topical corticosteroids) that didn't work well. Your AD should cover at least 10% of your body and be rated as moderate to severe by doctors. You cannot participate if you've recently used certain treatments, such as systemic corticosteroids or certain immunosuppressive agents.
Key Points:
- Participants will self-administer the medication at home.
- Eligibility requires a history of moderate-to-severe AD and unsuccessful past treatments.
- Cannot join if recently used specific medications or therapies.
How understandable was the trial content above?
Hard to understand
Easy to understand